Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage

被引:10
作者
Tursi, Antonio [1 ]
Elisei, Walter [2 ]
Brandimarte, Giovanni [3 ]
Giorgetti, Gian Marco [4 ]
Inchingolo, Cosimo Damiano [5 ]
Nenna, Rosanna [5 ]
Ierardi, Enzo [6 ]
机构
[1] ASL BAT, Serv Gastroenterol Terr, Andria, Italy
[2] ASL Roma H Albano Laziale, UOC Gastroenterol, Rome, Italy
[3] Osped Cristo Re, UOS Gastroenterol, Rome, Italy
[4] Osped S Eugenio, UOD Endoscopia Digest & Nutr, Rome, Italy
[5] ASL BAT, Osped Lorenzo Bonomo, UOC Anat & Istol Patol, Andria, Italy
[6] Univ Foggia, Sez Gastroenterol, Dipartimento Sci Med, Foggia, Italy
关键词
Endoscopy; Segmental colitis associated with diverticulosis; Tumoural necrosis factor alpha; ULCERATIVE-COLITIS; MAINTENANCE THERAPY; DOWN-REGULATION; CROHNS-DISEASE; INFLIXIMAB; INFLAMMATION; CYTOKINES; SPECTRUM; MARKER; CELLS;
D O I
10.1016/j.dld.2010.11.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Tumour necrosis factor-alpha expression may be increased in segmental colitis associated with diverticulosis. Aims: To assess tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis in relation with the severity of the endoscopic damage. Methods: 21 patients affected by segmental colitis associated with diverticulosis were studied (15 M, 6 F, mean age 58.87 years, range 43-85 years). Segmental colitis associated with diverticulosis was graduated as mild-moderate (patterns A and C) and severe (patterns B and D). Ten patients with moderate-to-severe ulcerative colitis, 10 patients with moderate-to-severe Crohn's disease, and 10 patients with irritable bowel syndrome served as control groups. Results: Tumour necrosis factor-alpha expression was significantly higher in segmental colitis associated with diverticulosis B (42.7%) and segmental colitis associated with diverticulosis D (40%) than in segmental colitis associated with diverticulosis A (19.1%) and segmental colitis associated with diverticulosis C (21.1%).Tumour necrosis factor-alpha expression was lower in segmental colitis associated with diverticulosis A and C than in ulcerative colitis and Crohn's disease, whilst no different tumour necrosis factor-alpha expression was found between segmental colitis associated with diverticulosis B and D and both ulcerative colitis and Crohn's disease.Finally, tumour necrosis factor-alpha expression was significantly lower in irritable bowel syndrome (8%+/- 4) than in every type of segmental colitis associated with diverticulosis. Conclusions: Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis seems to be related to the severity of the endoscopic damage. This behaviour, similar to that of the inflammatory bowel diseases (IBD), confirms that this disease should be considered as a subtype of IBD. (C) 2010 Editrice Gastroenterologica ltaliana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:374 / 379
页数:6
相关论文
共 50 条
[41]   Semen Quality and Sperm DNA Integrity in Patients With Severe Active Inflammatory Bowel Disease and Effects of Tumour Necrosis Factor-alpha Inhibitors [J].
Grosen, Anne ;
Bungum, Mona ;
Christensen, Lisbet Ambrosius ;
Cordelli, Eugenia ;
Larsen, Ole Halfdan ;
Leter, Giorgio ;
Julsgaard, Mette ;
Vestergaard, Thea ;
Villani, Paola ;
Hvas, Christian Lodberg ;
Kelsen, Jens .
JOURNAL OF CROHNS & COLITIS, 2019, 13 (05) :564-571
[42]   Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons [J].
Durham, Zachary L. ;
Hawkins, Jordan L. ;
Durham, Paul L. .
ARCHIVES OF ORAL BIOLOGY, 2017, 75 :100-106
[43]   Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: Indicators of an active inflammatory burden? [J].
Gotsman, Israel ;
Stabholz, Ayala ;
Planer, David ;
Pugatsch, Thea ;
Lapidus, Ludmila ;
Novikov, Yelena ;
Masrawa, Siham ;
Soskolne, Aubrey ;
Lotan, Chaim .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (07) :494-498
[44]   Anti-Tumor Necrosis Factor-Alpha Withdrawal in Children With Inflammatory Bowel Disease in Endoscopic and Histologic Remission [J].
Scarallo, Luca ;
Bolasco, Giulia ;
Barp, Jacopo ;
Bianconi, Martina ;
di Paola, Monica ;
Di Toma, Michele ;
Naldini, Sara ;
Paci, Monica ;
Renzo, Sara ;
Labriola, Flavio ;
De Masi, Salvatore ;
Alvisi, Patrizia ;
Lionetti, Paolo .
INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) :183-191
[45]   Tumour necrosis factor-alpha (TNF-alpha) stimulates the growth of human bone marrow stromal cells [J].
Rougier, F ;
Cornu, E ;
Gachard, N ;
Praloran, V ;
Denizot, Y .
MEDIATORS OF INFLAMMATION, 1997, 6 (03) :233-235
[46]   Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha [J].
Watkins, PE ;
Warren, BF ;
Stephens, S ;
Ward, P ;
Foulkes, R .
GUT, 1997, 40 (05) :628-633
[47]   Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa [J].
Mozeika, Elga ;
Pilmane, Mara ;
Nurnberg, Birgit Meinecke ;
Jemec, Gregor B. E. .
ACTA DERMATO-VENEREOLOGICA, 2013, 93 (03) :301-304
[48]   Mycosis fungoides in a patient with ulcerative colitis on anti-tumor necrosis factor-alpha therapy [J].
Yasuda, Takeshi ;
Takagi, Tomohisa ;
Asai, Jun ;
Katoh, Norito ;
Kuroda, Junya ;
Kuwahara, Yasumichi ;
Morinaga, Yukiko ;
Konishi, Eiichi ;
Uchiyama, Kazuhiko ;
Naito, Yuji ;
Itoh, Yoshito .
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) :170-175
[49]   Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist [J].
Hayashida, Sho ;
Sato, Shunsuke ;
Shimada, Yuji ;
Tsuzura, Hironori ;
Ikeda, Yuji ;
Takahashi, Sho ;
Sato, Sho ;
Amano, Nozomi ;
Murata, Ayato ;
Nagahara, Akihito ;
Genda, Takuya .
INTERNAL MEDICINE, 2020, 59 (16) :1977-1981
[50]   Mycosis fungoides in a patient with ulcerative colitis on anti-tumor necrosis factor-alpha therapy [J].
Takeshi Yasuda ;
Tomohisa Takagi ;
Jun Asai ;
Norito Katoh ;
Junya Kuroda ;
Yasumichi Kuwahara ;
Yukiko Morinaga ;
Eiichi Konishi ;
Kazuhiko Uchiyama ;
Yuji Naito ;
Yoshito Itoh .
Clinical Journal of Gastroenterology, 2021, 14 :170-175